Clinical Trial Update: Phase II Avastin + Bortezomib for Patients With Recurrent Malignant Glioma [Phase 2]

View source ↗

Summary

A Phase II study evaluating bevacizumab (Avastin) with bortezomib for recurrent malignant glioma has completed and posted results, involving glioblastoma and gl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Gliosarcoma

Drugs mentioned

• Avastin (bevacizumab)
• Velcade (bortezomib)

Snippet

Sponsor: Duke University | Conditions: Glioblastoma, Gliosarcoma | Phase 2 | Status: COMPLETED | Results posted: 2014-02-04